Intra-Cellular Therapies
ITCI
#1295
Rank
NZ$24.27 B
Marketcap
$228.33
Share price
-0.08%
Change (1 day)
115.86%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.60

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.80. In 2022 the company made an earnings per share (EPS) of -$4.73 an increase over its 2021 EPS that were of -$6.09.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.60-45.02%
2022-$4.73-22.29%
2021-$6.098.02%
2020-$5.6420.9%
2019-$4.66-5.63%
2018-$4.9433.96%
2017-$3.69-21.19%
2016-$4.68-7.56%
2015-$5.06174.53%
2014-$1.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.43-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.40 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.72 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA